> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Comments Extended on 510(k)/CLIA App Studies
- URL: https://www.fdaweb.com/comments-extended-on-510-k-clia-app-studies/
- Published: 2018-01-25T12:00:00.000Z
- Updated: 2026-09-14T23:17:09.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5140600

*Federal Register* notice: FDA has extended the comment period on a draft guidance entitled “Recommendations for Dual 510(k) and Clinical Laboratory Improvement Amendments (CLIA) Waiver by Application Studies.” Comments can now be submitted until 3/30\. To view the notice, click [here](https://s3.amazonaws.com/public-inspection.federalregister.gov/2018-01350.pdf?ref=fdaweb.com).